Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Uterine Cervical Neoplasms 2Uterine Cervical Dysplasia 2Mouth Neoplasms 2Breast Neoplasms 2Tobacco Use Disorder 1Stomatitis 1Precancerous Conditions 1Neoplasms 1Multiple Myeloma 1Lichen Planus 1Leukokeratosis, Hereditary Mucosal 1Immunoglobulin Light-chain Amyloidosis 1Head and Neck Neoplasms 1Fanconi Anemia 1Erythroplasia 1

Interventions

pembrolizumab 185Gemcitabine 170Paclitaxel 152Carboplatin 137Bevacizumab 128Surveys and Questionnaires 118Cisplatin 115Docetaxel 114Blood Specimen Collection 110Cyclophosphamide 109Exercise 108Nivolumab 98Fluorouracil 90Capecitabine 86Dexamethasone 81Radiotherapy 80Irinotecan 74Standard of Care 69Pemetrexed 68Oxaliplatin 68Leucovorin 64Drug Therapy 64Cetuximab 60Erlotinib Hydrochloride 56Sorafenib 53atezolizumab 52Ipilimumab 51Doxorubicin 50trametinib 47Interviews as Topic 47

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms × Spectrometry, Fluorescence × Clear all
NCT00507182 2018-01-19

Spectroscopy for Diagnostic Assessment of Oral Mucosal Lesions

M.D. Anderson Cancer Center

Phase NA Completed
381 enrolled
Head & Neck

Mouth Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡